title: High-dose epirubicin + cyclophosphamide (HD-EC) in metastatic breast cancer: a dose-finding study.
authors.affiliation: Department of Internal Medicine, University Hospital Göttingen.
authors.forename: G A
authors.initials: GA
authors.lastname: Nagel
authors.forename: J H
authors.initials: JH
authors.lastname: Beyer
authors.forename: W
authors.initials: W
authors.lastname: Holtkamp
authors.forename: D
authors.initials: D
authors.lastname: Emrich
authors.forename: M
authors.initials: M
authors.lastname: Kneba
authors.forename: H
authors.initials: H
authors.lastname: Luig
authors.forename: N
authors.initials: N
authors.lastname: Marschner
authors.forename: W
authors.initials: W
authors.lastname: Rauschning
authors.forename: C
authors.initials: C
authors.lastname: Unger
authors.forename: H E
authors.initials: HE
authors.lastname: Wander
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis; D014751:Vindesine / Q000008:administration & dosage
chemical_list: D015251:Epirubicin; D003520:Cyclophosphamide; D014751:Vindesine; D005472:Fluorouracil